Provided herein is an application of a glutamine derivative in preparation of an animal feed additive, specifically, the application of a glutamine derivative the structure of which is shown in the following formula (I) or racemates, stereoisomers, geometric isomers, tautomers, solvates and feed-acceptable salts of the glutamine derivative in animal feed additives. Results of animal breeding tests show that the glutamine derivative or racemates, stereoisomers, geometric isomers, tautomers, solvates, feed acceptable salts and other compounds thereof may be used as animal feed additives and have good effects in improving animal growth, feed conversion and other production performances.

##STR00001##

Provided herein is an application of a glutamine derivative in preparation of an animal feed additive, specifically, the application of a glutamine derivative the structure of which is shown in the following formula (I) or racemates, stereoisomers, geometric isomers, tautomers, solvates and feed-acceptable salts of the glutamine derivative in animal feed additives. Results of animal breeding tests show that the glutamine derivative or racemates, stereoisomers, geometric isomers, tautomers, solvates, feed acceptable salts and other compounds thereof may be used as animal feed additives and have good effects in improving animal growth, feed conversion and other production performances.

##STR00001##

Disclosed herein is a preoperative beverage that is formulated to be administered prior to an operation or surgical procedure. In particular, the preoperative beverage is a water-based beverage that is configured to provide a patient with calories and nutrients while also maintaining an osmolality that is suitable for preoperative use The preoperative beverage may have a pH greater than approximately 4.3, one or more carbohydrates to provide at least 200 calories, and an osmolality ranging between 250-300 mOsm to facilitate absorption in less than two hours. The preoperative beverage may also include one or more amino acids, as well as other nutritional supplements to facilitate the health and comfort of the patient before and after the operation or surgical procedure.

Disclosed herein is a preoperative beverage that is formulated to be administered prior to an operation or surgical procedure. In particular, the preoperative beverage is a water-based beverage that is configured to provide a patient with calories and nutrients while also maintaining an osmolality that is suitable for preoperative use The preoperative beverage may have a pH greater than approximately 4.3, one or more carbohydrates to provide at least 200 calories, and an osmolality ranging between 250-300 mOsm to facilitate absorption in less than two hours. The preoperative beverage may also include one or more amino acids, as well as other nutritional supplements to facilitate the health and comfort of the patient before and after the operation or surgical procedure.

A composition for fortifying food and/or beverages comprising a complex of Fe(III), phytic acid and an amino compound selected from the group consisting of ammonium hydroxide; ammonium carbonate; ammonium phosphate dibasic; ammonium sodium phosphate dibasic and triammonium phosphate.

A composition for fortifying food and/or beverages comprising a complex of Fe(III), phytic acid and an amino compound selected from the group consisting of ammonium hydroxide; ammonium carbonate; ammonium phosphate dibasic; ammonium sodium phosphate dibasic and triammonium phosphate.

The present invention aims to provide a food containing, as a main ingredient, a foodstuff produced in developing regions with many malnourished patients, specifically at least one kind of grain selected from the group consisting of soybean, maize and sorghum, which contains sufficient protein/amino acid nutrients, is easy to take even without water, and provides a high improving effect on malnutrition (especially severe acute malnutrition).

The present invention relates to a food containing at least one grain selected from the group consisting of soybean, maize and sorghum, lysine or a salt thereof, glutamine or a salt thereof, and methionine or a salt thereof.

The present invention aims to provide a food containing, as a main ingredient, a foodstuff produced in developing regions with many malnourished patients, specifically at least one kind of grain selected from the group consisting of soybean, maize and sorghum, which contains sufficient protein/amino acid nutrients, is easy to take even without water, and provides a high improving effect on malnutrition (especially severe acute malnutrition).

The present invention relates to a food containing at least one grain selected from the group consisting of soybean, maize and sorghum, lysine or a salt thereof, glutamine or a salt thereof, and methionine or a salt thereof.

The invention relates to a nutritional composition comprising (a) at least 18 en % of proteinaceous matter, said proteinaceous matter comprising whey; (b) at least 12 wt % of leucine, based on total proteinaceous matter; and (c) a lipid fraction comprising at least a ?-3 polyunsaturated fatty acid selected from the group of eicosapentaenoic acid, docosahexaenoic acid, eicosatetraenoic acid and docosapentaenoic acid for improving the muscle function in a mammal, for improving daily activity, for improving physical performance, for providing a better prognosis in terms of extended life-expectancy, for improving compliance to an anti-cancer therapy or for improving a quality of life.

The invention relates to a nutritional composition comprising (a) at least 18 en % of proteinaceous matter, said proteinaceous matter comprising whey; (b) at least 12 wt % of leucine, based on total proteinaceous matter; and (c) a lipid fraction comprising at least a ?-3 polyunsaturated fatty acid selected from the group of eicosapentaenoic acid, docosahexaenoic acid, eicosatetraenoic acid and docosapentaenoic acid for improving the muscle function in a mammal, for improving daily activity, for improving physical performance, for providing a better prognosis in terms of extended life-expectancy, for improving compliance to an anti-cancer therapy or for improving a quality of life.